Maternal mental health is making headlines. Experts say it’s long overdue

A Long-Overdue Reckoning: How Two Tragedies Forced America to Confront Maternal Mental Health

Goldlaner.com – The summer of 2026 brought an unlikely convergence of events that thrust maternal mental health from whispered conversations into the national spotlight. A labor-and-delivery nurse named Lindsay Clancy, 36, stood trial accused of strangling her three young children during an episode of postpartum psychosis. Days later, actress Hayden Panettiere, who had spent two decades as a familiar face on screen and had spoken openly about her own postpartum depression, was found dead at age 36. Together, these two stories ignited a wave of public testimony, advocacy, and institutional scrutiny that experts describe as a long-delayed moment of accountability for a healthcare system that has repeatedly failed mothers in crisis.

The Scale of the Problem

Postpartum psychosis is rare but severe, striking roughly two out of every 1,000 women in the weeks following delivery. It can produce hallucinations, delusions, and a complete disconnection from reality. Yet it sits at one end of a much broader spectrum. Depression, anxiety, and other mental-health conditions affect as many as one in five American women during pregnancy and throughout the first year after birth. For decades, a culture of shame kept those conditions hidden — undiscussed at family dinners, undetected at well-baby visits, and untreated until a crisis made silence impossible.

Many Americans learned the clinical term “postpartum psychosis” for the first time only through coverage of the Clancy trial. That gap in public knowledge underscores how little the condition has been explained outside specialized medical circles, despite its devastating potential.

A Mother’s Six-Month Wait

Adrienne Griffen experienced the system’s failures firsthand in 2001, shortly after delivering her second child. The mild “baby blues” that had faded quickly after her first pregnancy returned with far greater intensity this time. When she sought guidance from her physician, the conversation took a turn she has never forgotten.

“I am here to get help, so I don’t hurt my children,” she told her doctor.

The physician’s reply, as Griffen recalls it, was blunt and chilling:

“Well, we don’t want another Andrea Yates.”

Yates, a Texas mother, had drowned her five children in a bathtub that same year. The reference landed like a verdict rather than a reassurance. Griffen then waited another six months before receiving adequate treatment for her postpartum depression.

“It was like banging my head against a brick wall,” she said.

Griffen, now chief executive of the Maternal Mental Health Leadership Alliance, says twenty-five years of advocacy have shifted some attitudes but not enough. The architecture of care — hospital discharge protocols, primary-care follow-up, insurance coverage for behavioral-health visits — still leaves too many mothers stranded between the delivery room and a functioning support network.

Panettiere’s Public Struggle and a Brand’s Silence

Hayden Panettiere grew up starring in major studio films, and generations of young women saw themselves in the bold, layered characters she portrayed. Years later, those same viewers recognized themselves in Panettiere’s own candid accounts of motherhood’s difficulties. In a May podcast interview, she described the landscape of postpartum experience:

“There’s a lot of stigma around postpartum, and there’s a lot of misunderstanding. It’s on a spectrum. It’s on a scale, and fortunately, I never felt any hostility or negativity towards my child, thankfully, but I wasn’t connecting with her the way that I knew I should be.”

Panettiere had also endured a professional consequence for speaking out. After discussing her postpartum depression on national television in 2015, she was dropped from a brand partnership with Neutrogena that had run for more than a decade. The company’s decision went largely unexamined until after her death, when Neutrogena issued a public statement expressing deep sadness and acknowledging that the partnership had made her “feel unsupported during a very difficult time.”

“This is not what Neutrogena stands for or who we want to be,” the company wrote.

The statement, posted on a Thursday, arrived the same day hundreds of women assembled outside the courthouse where Clancy’s trial was underway, dressed in bright pink to signal solidarity and demand greater awareness of maternal mental-health needs.

Systemic Gaps and the Path Forward

Griffen points to a structural absurdity at the heart of postpartum care: a new mother, still recovering surgically, still navigating hormonal upheaval, is discharged from one hospital bed only to assume full responsibility for another patient — an infant — with minimal transitional support.

“In no other situation do we have one hospital patient, the mother, caring for another hospital patient, the baby,” she observed.

Care coordinators, the professionals tasked with helping patients navigate complex medical systems, are routinely assigned to those diagnosed with cancer or other life-threatening conditions. New mothers, by contrast, often receive a pamphlet, a phone number, and a well-meaning but under-resourced follow-up call. The result is a pipeline in which symptoms go unrecognized for weeks or months, and by the time help arrives, the window for intervention has narrowed dramatically.

The convergence of Clancy’s trial and Panettiere’s death has given advocates a rare platform: mainstream media coverage, public sympathy, and political attention that maternal-mental-health organizations have sought for years. Whether that attention translates into sustained funding for postpartum screening, expanded insurance coverage for behavioral-health visits, and redesigned hospital discharge protocols remains the central question. For Griffen and the thousands of mothers who have shared their stories online, at work, and in public, the answer cannot be another six-month wait.